Mater Private Network first in Europe to join FARADIGM trial of next-generation AF Ablation Techn

Mater Private Network has announced its participation in the FARADIGM clinical trial, a global study evaluating the safety and effectiveness of Boston Scientific’s FaraFlex™ Mapping and Pulsed Field Ablation Catheter for the treatment of patients with paroxysmal and persistent atrial fibrillation (AF). Mater Private Network is among the first centres worldwide to participate in the […]